Here are the DEF 14A proxy statements from GoHealth, Inc. (GOCO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow GOCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GOCO filings page.
GoHealth, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on June 17, 2026. Investors will elect three Class III directors, ratify Ernst & Young LLP as independent auditor for the year ending December 31, 2026, and cast an advisory say‑on‑pay vote on named executive officer compensation.
As of April 22, 2026, voting securities included 50,000 shares of Series A Convertible Perpetual Preferred Stock, 16,686,419 shares of Class A common stock and 12,616,074 shares of Class B common stock. CEO Vijay Kotte received 2025 total compensation of $13,757,255, while Ernst & Young LLP billed 2025 audit and related fees of $3,824,769 and tax fees of $139,985.